Anika Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 9.33, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Anika Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 39 days, from 22 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 206 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1467 to 1659.

What is Receivable Turnover Ratio?
What is Anika Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ANIK Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	10.91 %	19.18 %	12.91 %	-	-28.24 %
Receivable Turnover Ratio (TTM)	9.33	16.7	-	-	-
ANIK's Total Ranking	# 1659	# 1467	# 1407	# 1520	#
Accounts Receivable average collection period days	39	22	-	-	-
Seq. Receivable Change	-16.54 %	-	-	-	-
Seq. Revenue Change	-6.18 %	12.46 %	-9.89 %	16.66 %	0.81 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 91
Healthcare Sector	# 207
Overall Market	# 1659

Receivable Turnover Ratio Statistics
High	Average	Low
0.69	0.48	0.32
(Dec 31 2024)		(Sep 30 2020)

ANIK Company Profile • Back to ANIK Efficiency Comparisons • Compare ANIK Receivables Turnover Ratio to its Competitors

Financial Statements
Anika Therapeutics Inc 's Accounts Receivable	$ 24 Millions	Visit ANIK's Balance sheet
Anika Therapeutics Inc 's Sales TTM	$ 124 Millions	Visit ANIK's Income Statement
Sources of ANIK's Revenues		Visit ANIK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ANIK's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ANIK's Growth Rates	ANIK's Roa	ANIK's Inventory Turnover Ratio	ANIK's Dividend Comparisons
ANIK's Profitability Ratios	ANIK's Roi	ANIK's Asset Turnover Ratio	ANIK's Dividend Growth
ANIK's Valuation Ratios	ANIK's Roe	ANIK's Financial Strength Ratios	ANIK's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Lifemd Inc	13.58	$ 148.224 Millions	$ 10.917 Millions
Corcept Therapeutics Inc	13.44	$ 963.647 Millions	$ 71.710 Millions
Precipio inc	13.38	$ 27.762 Millions	$ 2.075 Millions
Volitionrx Limited	13.38	$ 3.445 Millions	$ 0.258 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Biodesix Inc	11.45	$ 105.212 Millions	$ 9.192 Millions
Gossamer Bio Inc	11.37	$ 78.423 Millions	$ 6.896 Millions
Lineage Cell Therapeutics Inc	11.35	$ 10.836 Millions	$ 0.955 Millions
Qhslab Inc	11.33	$ 2.957 Millions	$ 0.261 Millions
Icu Medical Inc	11.32	$ 2,183.556 Millions	$ 192.845 Millions
Mannkind Corporation	10.97	$ 413.370 Millions	$ 37.686 Millions
Seastar Medical Holding Corp	10.80	$ 2.165 Millions	$ 0.200 Millions
Lensar Inc	10.64	$ 60.079 Millions	$ 5.645 Millions
Immucell Corporation	10.48	$ 32.454 Millions	$ 3.096 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Voyager Therapeutics Inc	9.84	$ 25.108 Millions	$ 2.551 Millions
Myomo Inc	9.66	$ 47.775 Millions	$ 4.947 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Sunshine Biopharma Inc	9.19	$ 35.372 Millions	$ 3.850 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Co diagnostics Inc	9.12	$ 0.859 Millions	$ 0.094 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Sanara Medtech Inc	8.69	$ 113.087 Millions	$ 13.019 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions

Date modified: 2026-11-08T13:37:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.